Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.62 |
| ▸ | MAG | P20916 | 7/20 | 0.57 |
| ▸ | SELP | P16109 | 2/20 | 0.54 |
| ▸ | SELL | P14151 | 1/20 | 0.54 |
| ▸ | SELE | P16581 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL769119 | 0.90 | SIGLEC7 (0.66) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL18213994 | 0.87 | SIGLEC7 (0.58) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL18214007 | 0.87 | SIGLEC7 (0.59) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL25964211 | 0.87 | SIGLEC7 (0.60) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL17718783 | 0.86 | MAG (0.62) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL19726167 | 0.86 | SIGLEC7 (0.62) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL12903204 | 0.86 | SELP (0.65) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL18214011 | 0.86 | SIGLEC7 (0.58) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL17903036 | 0.86 | SELP (0.66) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL12903230 | 0.86 | SELP (0.66) | SIGLEC7MAGSELPSELLSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110059501-A1 | Protein Glycosylation | ISIS INNOVATION LIMITED (GB) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110059501-A1 | Protein Glycosylation | OGA, LGALS3BP, ENGASE | SIGLEC7 22/4885MAG 410/4885SELP 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.